Scispot, a Kitchener-Waterloo-based laboratory informatics company, has announced the completion of an $8 million Series A financing round led by Avenue Growth Partners. The investment will support the expansion of the company’s product development, AI engineering, and customer success teams as it scales its platform globally.
The company focuses on addressing a longstanding challenge across life sciences research and diagnostics: fragmented laboratory data and disconnected operational systems. Despite advances in laboratory automation and sequencing technologies, many organizations continue to rely on a combination of spreadsheets, electronic lab notebooks (ELNs), laboratory information management systems (LIMS), and isolated data repositories that require extensive manual coordination.
Scispot’s platform is designed to serve as a unified, AI-native operating layer that connects laboratory instruments, workflows, samples, protocols, and compliance processes within a single environment. By automating data movement and contextualizing laboratory activities in real time, the company aims to reduce administrative burden while improving traceability and operational efficiency.
According to Scispot, its infrastructure is currently deployed across more than 100 enterprise laboratories spanning biotechnology, pharmaceutical development, diagnostics, genomics, contract research organizations (CROs), and manufacturing environments. The platform supports more than 250 instrument types and manages millions of production samples.
The company’s architecture captures operational context throughout the research process, linking sample tracking, instrument outputs, workflow states, electronic signatures, approvals, and audit records. This approach is intended to support both laboratory operations and emerging artificial intelligence applications that depend on high-quality, structured scientific data.
Key platform capabilities include:
Automated workflow integration across high-throughput testing, biobanking, bioproduction, and research environments.
Compatibility with more than 250 laboratory instrument types.
Built-in compliance features, including audit trails, permissions management, validation checkpoints, and inspection readiness tools.
“Future labs will not run on people stitching together instruments, spreadsheets, reports, and approval steps,” said Guru Singh, founder and CEO of Scispot. “They will run on an operating layer that connects every sample, instrument run, workflow, result, approval, and decision as the work happens. Scispot has built that layer, so scientists stay in control while routine digital work runs in the background.”
Beyond workflow automation, Scispot positions its platform as foundational infrastructure for life sciences AI development. The company argues that access to high-fidelity, traceable laboratory data remains one of the primary barriers to successful AI implementation in drug discovery, diagnostics, and research operations.
By creating structured context around laboratory activities and maintaining data provenance throughout the research lifecycle, Scispot aims to provide a reliable data foundation for AI agents, machine learning models, and scientific teams seeking to accelerate discovery and operational decision-making.
Click here for the original news story.
